Human cytomegalovirus DNAemia and preemptive treatment of CMV infection in children after hematopoietic stem-cell transplantation: Is any question settled?

被引：0
|
作者：
Cesaro, Simone [1 ]
Abate, Davide [1 ]
Mengoli, Carlo [1 ]
机构：
[1] Univ Padua, Dept Pediat, I-35100 Padua, PD, Italy
来源：
BLOOD | 2008年 / 111卷 / 08期
关键词：
D O I：
10.1182/blood-2008-01-131508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4419 / 4419
页数：1
相关论文
共 50 条
  • [1] Human cytomegalovirus DNAemia and preemptive treatment of HCMV infection in children receiving hematopoietic stem-cell transplantation - Response
    Gerna, Giuseppe
    Lilleri, Daniele
    Locatelli, Franco
    [J]. BLOOD, 2008, 111 (08) : 4420 - 4420
  • [2] Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation
    Maffini, Enrico
    Giaccone, Luisa
    Festuccia, Moreno
    Brunello, Lucia
    Busca, Alessandro
    Bruno, Benedetto
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (06) : 585 - 596
  • [3] Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease
    Bordon, V.
    Bravo, S.
    Van Renterghem, L.
    de Moerloose, B.
    Benoit, Y.
    Laureys, G.
    Dhooge, C.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (01) : 19 - 23
  • [4] Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients
    Gerna, G.
    Lilleri, D.
    Caldera, D.
    Furione, M.
    Bragotti, L. Zenone
    Alessandrino, E. P.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 (10) : 873 - 879
  • [5] Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation
    Jaing, Tang-Her
    Chang, Tsung-Yen
    Chen, Shih-Hsiang
    Wen, Yu-Chuan
    Yu, Ting-Jiuan
    Lee, Ching-Fen
    Yang, Chao-Ping
    Tsay, Pei-Kwei
    [J]. MEDICINE, 2019, 98 (04)
  • [6] Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients
    G Gerna
    D Lilleri
    D Caldera
    M Furione
    L Zenone Bragotti
    E P Alessandrino
    [J]. Bone Marrow Transplantation, 2008, 41 : 873 - 879
  • [7] USE OF CMV HYPERIMMUNOGLOBULINS (CYTOTECT) AS PREEMPTIVE TREATMENT OF CMV INFECTION IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION - A SINGLE CENTRE EXPERIENCE
    Desnica, Lana
    Durakovic, Nadira
    Peric, Zinaida
    Serventi-Seiwerth, Ranka
    Roncevic, Pavle
    Sertic, Dubravka
    Mikulic, Mirta
    Pulanic, Drazen
    Vrhovac, Radovan
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 430 - 431
  • [8] Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation
    Ju, H. Y.
    Kang, H. J.
    Hong, C. R.
    Lee, J. W.
    Kim, H.
    Park, K. D.
    Shin, H. Y.
    Park, J. D.
    Choi, E. H.
    Lee, H. J.
    Ahn, H. S.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (03) : 396 - 404
  • [9] Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation
    Luis Pinana, Jose
    Perez-Pitarch, Alejandro
    Guglieri-Lopez, Beatriz
    Gimenez, Estela
    Carlos Hernandez-Boluda, Juan
    Jose Terol, Maria
    Ferriols-Lisart, Rafael
    Solano, Carlos
    Navarro, David
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (12) : 2885 - 2894
  • [10] Valganciclovir is effective in the preemptive treatment of cytomegalovirus (CMV) infection after allogeneic stem cell transplant (ASCT)
    Aberle, MF
    Bachier, C
    Lemaistre, FC
    Shaughnessy, PJ
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 136 - 136
12345